Incessant pericardial effusion in a 9 year old male responding to infliximab.
Recurrent idiopathic pericardial effusion can be a challenging medical problem. Multiple medical interventions may yield minimal improvement. We describe a patient with an incessant pericardial effusion that responded to infliximab. The use of infliximab should be considered in the management of recurrent pericardial effusions resistant to other treatment modalities.
Walsh
Rowan F
RF
Department of Pediatrics, Division of Pediatric Cardiology, Schneider Children's Hospital, New Hyde Park, New York, USA. rowando@eircom.net
Chowdhury
Devyani
D
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D010490:Pericardial Effusion / Q000188:drug therapy*; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab